SCHEMBL9968293

SCHEMBL9968293

CCCCN(C)c1cc(-c2nc3ccccc3n2C)c(Cl)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
PDE2A O00408 1/20 0.40
KDM4E B2RXH2 5/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 3/20 0.40
HTT P42858 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TP53 P04637 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
GFER P55789 1/20 0.40
GAA P10253 3/20 0.39
GRM5 P41594 2/20 0.39
ATP4A P20648 1/20 0.39
ATP4B P51164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968296 0.93 MEN1 (0.45) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9932761 0.90 MEN1 (0.43) MEN1KMT2APDE2AKDM4EMAPT
SCHEMBL9968510 0.88 MEN1 (0.44) MEN1KMT2APDE2AKDM4EMAPT
SCHEMBL9932202 0.88 MEN1 (0.44) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9932409 0.84 MEN1 (0.41) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9971209 0.82 MEN1 (0.39) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9968458 0.82 KMT2A (0.43) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9968292 0.82 MEN1 (0.43) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9968512 0.81 MEN1 (0.42) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL1533963 0.77 MEN1 (0.62) MEN1KMT2AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES SMO, RB1, GLI1 MEN1 1168/4885KMT2A 310/4885PDE2A 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.